COUR Fundamental Analysis - COURTOIS-R

Fundamental Rating

Overall COUR gets a fundamental rating of 2 out of 10. We evaluated COUR against 73 industry peers in the Real Estate Management & Development industry. The financial health of COUR is average, but there are quite some concerns on its profitability. COUR does not seem to be growing, but still is valued expensively.

Quickly go to:

1. Profitability

1.1 Basic Checks

COUR had negative earnings in the past year.

In the past year COUR has reported a negative cash flow from operations.

In multiple years COUR reported negative net income over the last 5 years.

In multiple years COUR reported negative operating cash flow during the last 5 years.

1.2 Ratios

Looking at the Return On Assets, with a value of -2.18%, COUR is doing worse than 71.23% of the companies in the same industry.

COUR's Return On Equity of -3.31% is on the low side compared to the rest of the industry. COUR is outperformed by 63.01% of its industry peers.

		Industry Rank	Sector Rank
ROA	-2.18%
ROE	-3.31%
ROIC	N/A

ROA(3y)0.22%

ROA(5y)0.22%

ROE(3y)0.24%

ROE(5y)0.3%

ROIC(3y)N/A

ROIC(5y)N/A

1.3 Margins

The Profit Margin and Operating Margin and Gross Margin are not available for COUR so they could not be analyzed.

		Industry Rank	Sector Rank
OM	N/A
PM (TTM)	N/A
GM	N/A

OM growth 3YN/A

OM growth 5YN/A

PM growth 3YN/A

PM growth 5YN/A

GM growth 3YN/A

GM growth 5YN/A

More info and screens

ROA

ROE

ROIC

Operating and Profit Margin

Show most profitable peers

2. Health

2.1 Basic Checks

COUR does not have a ROIC to compare to the WACC, probably because it is not profitable.

COUR has about the same amout of shares outstanding than it did 1 year ago.

COUR has less shares outstanding than it did 5 years ago.

COUR has a worse debt/assets ratio than last year.

2.2 Solvency

COUR has an Altman-Z score of 1.81. This is not the best score and indicates that COUR is in the grey zone with still only limited risk for bankruptcy at the moment.

The Altman-Z score of COUR (1.81) is better than 79.45% of its industry peers.

COUR has a Debt/Equity ratio of 0.06. This is a healthy value indicating a solid balance between debt and equity.

COUR has a better Debt to Equity ratio (0.06) than 84.93% of its industry peers.

		Industry Rank	Sector Rank
Debt/Equity	0.06
Debt/FCF	N/A
Altman-Z	1.81

ROIC/WACCN/A

WACC6.34%

2.3 Liquidity

COUR has a Current Ratio of 4.15. This indicates that COUR is financially healthy and has no problem in meeting its short term obligations.

Looking at the Current ratio, with a value of 4.15, COUR belongs to the top of the industry, outperforming 82.19% of the companies in the same industry.

A Quick Ratio of 2.21 indicates that COUR has no problem at all paying its short term obligations.

COUR has a better Quick ratio (2.21) than 78.08% of its industry peers.

		Industry Rank	Sector Rank
Current Ratio	4.15
Quick Ratio	2.21

More info and screens

WACC

Debt/Equity

How to determine the health of a company

Altman-Z score

Show peers with great health

3. Growth

3.1 Past

The earnings per share for COUR have decreased strongly by -114.32% in the last year.

Looking at the last year, COUR shows a quite strong growth in Revenue. The Revenue has grown by 9.56% in the last year.

Measured over the past years, COUR shows a very negative growth in Revenue. The Revenue has been decreasing by -30.36% on average per year.

EPS 1Y (TTM)-114.32%

EPS 3YN/A

EPS 5YN/A

EPS Q2Q%-139.46%

Revenue 1Y (TTM)9.56%

Revenue growth 3Y-38.77%

Revenue growth 5Y-30.36%

Sales Q2Q%124.25%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.

No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

EPS Next YN/A

EPS Next 2YN/A

EPS Next 3YN/A

EPS Next 5YN/A

Revenue Next YearN/A

Revenue Next 2YN/A

Revenue Next 3YN/A

Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.

No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

More info and screens

Find the best growth stocks

Show best growing peers

4. Valuation

4.1 Price/Earnings Ratio

COUR reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.

		Industry Rank	Sector Rank
PE	N/A
Fwd PE	N/A

4.2 Price Multiples

		Industry Rank	Sector Rank
P/FCF	N/A
EV/EBITDA	N/A

4.3 Compensation for Growth

PEG (NY)N/A

PEG (5Y)N/A

EPS Next 2YN/A

EPS Next 3YN/A

More info and screens

Show best valued peers

5. Dividend

5.1 Amount

COUR has a Yearly Dividend Yield of 2.02%. Purely for dividend investing, there may be better candidates out there.

Compared to an average industry Dividend Yield of 7.36, COUR has a dividend in line with its industry peers.

COUR's Dividend Yield is comparable with the S&P500 average which is at 2.32.

		Industry Rank	Sector Rank
Dividend Yield	2.02%

5.2 History

Dividend Growth(5Y)N/A

Div Incr Years0

Div Non Decr Years0

5.3 Sustainability

DP0%

EPS Next 2YN/A

EPS Next 3YN/A

More info and screens

Find the best dividend stocks

Show peers with best dividend

COURTOIS-R

EPA:COUR (11/24/2025, 7:00:00 PM)

116

-1 (-0.85%)

Chartmill FA Rating

GICS SectorReal Estate

GICS IndustryGroupEquity Real Estate Investment Trusts (REITs)

GICS IndustryReal Estate Management & Development

Earnings (Last)N/A N/A

Earnings (Next)N/A N/A

Inst OwnersN/A

Inst Owner ChangeN/A

Ins Owners80.73%

Ins Owner ChangeN/A

Market Cap8.12M

Revenue(TTM)1.57M

Net Income(TTM)-603.00K

Analysts78.82

Price TargetN/A

Short Float %N/A

Short RatioN/A

Dividend

		Industry Rank	Sector Rank
Dividend Yield	2.02%

Yearly Dividend0

Dividend Growth(5Y)N/A

DP0%

Div Incr Years0

Div Non Decr Years0

Ex-DateN/A

Surprises & Revisions

EPS beat(2)N/A

Avg EPS beat(2)N/A

Min EPS beat(2)N/A

Max EPS beat(2)N/A

EPS beat(4)N/A

Avg EPS beat(4)N/A

Min EPS beat(4)N/A

Max EPS beat(4)N/A

EPS beat(8)N/A

Avg EPS beat(8)N/A

EPS beat(12)N/A

Avg EPS beat(12)N/A

EPS beat(16)N/A

Avg EPS beat(16)N/A

Revenue beat(2)N/A

Avg Revenue beat(2)N/A

Min Revenue beat(2)N/A

Max Revenue beat(2)N/A

Revenue beat(4)N/A

Avg Revenue beat(4)N/A

Min Revenue beat(4)N/A

Max Revenue beat(4)N/A

Revenue beat(8)N/A

Avg Revenue beat(8)N/A

Revenue beat(12)N/A

Avg Revenue beat(12)N/A

Revenue beat(16)N/A

Avg Revenue beat(16)N/A

PT rev (1m)N/A

PT rev (3m)N/A

EPS NQ rev (1m)N/A

EPS NQ rev (3m)N/A

EPS NY rev (1m)N/A

EPS NY rev (3m)N/A

Revenue NQ rev (1m)N/A

Revenue NQ rev (3m)N/A

Revenue NY rev (1m)N/A

Revenue NY rev (3m)N/A

Valuation

		Industry Rank	Sector Rank
PE	N/A
Fwd PE	N/A
P/S	5.17
P/FCF	N/A
P/OCF	N/A
P/B	0.45
P/tB	0.45
EV/EBITDA	N/A

EPS(TTM)-8.49

EYN/A

EPS(NY)N/A

Fwd EYN/A

FCF(TTM)-32.03

FCFYN/A

OCF(TTM)-8.63

OCFYN/A

SpS22.43

BVpS260.3

TBVpS260.3

PEG (NY)N/A

PEG (5Y)N/A

Graham NumberN/A

Profitability

		Industry Rank	Sector Rank
ROA	-2.18%
ROE	-3.31%
ROCE	N/A
ROIC	N/A
ROICexc	N/A
ROICexgc	N/A
OM	N/A
PM (TTM)	N/A
GM	N/A
FCFM	N/A

ROA(3y)0.22%

ROA(5y)0.22%

ROE(3y)0.24%

ROE(5y)0.3%

ROIC(3y)N/A

ROIC(5y)N/A

ROICexc(3y)N/A

ROICexc(5y)N/A

ROICexgc(3y)N/A

ROICexgc(5y)N/A

ROCE(3y)N/A

ROCE(5y)N/A

ROICexgc growth 3YN/A

ROICexgc growth 5YN/A

ROICexc growth 3YN/A

ROICexc growth 5YN/A

OM growth 3YN/A

OM growth 5YN/A

PM growth 3YN/A

PM growth 5YN/A

GM growth 3YN/A

GM growth 5YN/A

F-Score1

Asset Turnover0.06

Health

		Industry Rank	Sector Rank
Debt/Equity	0.06
Debt/FCF	N/A
Debt/EBITDA	N/A
Cap/Depr	4200%
Cap/Sales	104.33%
Interest Coverage	N/A
Cash Conversion	N/A
Profit Quality	N/A
Current Ratio	4.15
Quick Ratio	2.21
Altman-Z	1.81

F-Score1

WACC6.34%

ROIC/WACCN/A

Cap/Depr(3y)N/A

Cap/Depr(5y)N/A

Cap/Sales(3y)N/A

Cap/Sales(5y)N/A

Profit Quality(3y)N/A

Profit Quality(5y)N/A

High Growth Momentum

Growth

EPS 1Y (TTM)-114.32%

EPS 3YN/A

EPS 5YN/A

EPS Q2Q%-139.46%

EPS Next YN/A

EPS Next 2YN/A

EPS Next 3YN/A

EPS Next 5YN/A

Revenue 1Y (TTM)9.56%

Revenue growth 3Y-38.77%

Revenue growth 5Y-30.36%

Sales Q2Q%124.25%

Revenue Next YearN/A

Revenue Next 2YN/A

Revenue Next 3YN/A

Revenue Next 5YN/A

EBIT growth 1Y-112.12%

EBIT growth 3YN/A

EBIT growth 5YN/A

EBIT Next YearN/A

EBIT Next 3YN/A

EBIT Next 5YN/A

FCF growth 1Y45.92%

FCF growth 3YN/A

FCF growth 5YN/A

OCF growth 1Y82.32%

OCF growth 3YN/A

OCF growth 5YN/A

COURTOIS-R / COUR.PA FAQ

What is the ChartMill fundamental rating of COURTOIS-R (COUR.PA) stock?

ChartMill assigns a fundamental rating of 2 / 10 to COUR.PA.

What is the valuation status for COUR stock?

ChartMill assigns a valuation rating of 0 / 10 to COURTOIS-R (COUR.PA). This can be considered as Overvalued.

How profitable is COURTOIS-R (COUR.PA) stock?

COURTOIS-R (COUR.PA) has a profitability rating of 1 / 10.

How financially healthy is COURTOIS-R?

The financial health rating of COURTOIS-R (COUR.PA) is 6 / 10.

How sustainable is the dividend of COURTOIS-R (COUR.PA) stock?

The dividend rating of COURTOIS-R (COUR.PA) is 2 / 10 and the dividend payout ratio is 0%.

COURTOIS-R (COUR.PA) Stock Fundamental Analysis

1. Profitability

1.1 Basic Checks

1.2 Ratios

1.3 Margins

More info and screens

2. Health

2.1 Basic Checks

2.2 Solvency

2.3 Liquidity

More info and screens

3. Growth

3.1 Past

3.2 Future

3.3 Evolution

More info and screens

4. Valuation

4.1 Price/Earnings Ratio

4.2 Price Multiples

4.3 Compensation for Growth

More info and screens

5. Dividend

5.1 Amount

5.2 History

5.3 Sustainability

More info and screens

COURTOIS-R / COUR.PA FAQ

What is the ChartMill fundamental rating of COURTOIS-R (COUR.PA) stock?

What is the valuation status for COUR stock?

How profitable is COURTOIS-R (COUR.PA) stock?

How financially healthy is COURTOIS-R?

How sustainable is the dividend of COURTOIS-R (COUR.PA) stock?